» Articles » PMID: 27672217

The Role of MiRNA-21 and Epithelial Mesenchymal Transition (EMT) Process in Colorectal Cancer

Overview
Journal J Clin Pathol
Specialty Pathology
Date 2016 Sep 28
PMID 27672217
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The study was conducted to assess the expression levels of epithelial mesenchymal transition (EMT) proteins (E-cadherin, N-cadherin, snail-1 and vimentin) and miRNA-21. In addition, we correlated these data with clinicopathological features in Colorectal cancer.

Methods: H&E slides from a total of 59 formalin fixed paraffin embedded tissue blocks were examined by a pathologist to demarcate normal and tumour regions. Immunohistochemical analysis of mismatch repair proteins (MLH1, MSH2 and MSH6) and EMT markers (E-cadherin, N-cadherin, snail-1 and vimentin) was performed. The miRNA-21 expression levels were determined using qRT-PCR and the data was analysed using the relative quantification method. The Fisher's exact and Pearson's χ tests were used to correlate snail-1, E-cadherin, miRNA-21 and clinicopathological data.

Results: Our results showed a statistically significant correlation between high miRNA-21 expression levels and E-cadherin positive cases. There was also an association between high miRNA-21 expression levels and negative snail-1 expression. No significant correlation was seen between miRNA-21 expression levels and clinicopathological features. Moreover, high expression levels of miRNA-21 were significantly associated with the sporadic cases.

Conclusions: Our data suggest that miRNA-21 in association with E-cadherin and snail-1 does not play a significant role in the development and progression of this disease.

Citing Articles

Association between the expression of epithelial-mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer.

Emile M, Emile S, El-Karef A, Ebrahim M, Mohammed I, Ibrahim D Updates Surg. 2024; 76(6):2181-2191.

PMID: 38762631 PMC: 11541317. DOI: 10.1007/s13304-024-01865-9.


BMSC-derived Exosomes Ameliorate Peritoneal Dialysis-associated Peritoneal Fibrosis via the Mir-27a-3p/TP53 Pathway.

Zhao J, Zhao L, Zhan Q, Liu M, Zhang T, Chu W Curr Med Sci. 2024; 44(2):333-345.

PMID: 38622424 DOI: 10.1007/s11596-024-2853-7.


MicroRNA-183 cluster: a promising biomarker and therapeutic target in gastrointestinal malignancies.

Zheng Y, Sukocheva O, Tse E, Neganova M, Aleksandrova Y, Zhao R Am J Cancer Res. 2024; 13(12):6147-6175.

PMID: 38187051 PMC: 10767355.


An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer.

Nagainallur Ravichandran S, Kumar M, Das A, Banerjee A, Veronica S, Sun-Zhang A Curr Cancer Drug Targets. 2023; 24(6):595-611.

PMID: 38031267 DOI: 10.2174/0115680096270555231113074003.


MicroRNAs and colorectal cancer: clinical potential and regulatory networks.

Osei G, Adu-Amankwaah J, Koomson S, Beletaa S, Asiamah E, Smith-Togobo C Mol Biol Rep. 2023; 50(11):9575-9585.

PMID: 37776413 DOI: 10.1007/s11033-023-08810-w.